The medical-products giant saw its stock plunge 10 percent after Reuters published a lengthy investigation citing documents, many decades old, that emerged in litigation.
from Washington Post: Breaking News, World, US, DC News & Analysis https://ift.tt/2EmHj5j
Subscribe to:
Post Comments (Atom)
-
By BY NEW YORK TIMES AUDIO from NYT Podcasts https://ift.tt/8Zjh7kA
-
By BY EITAN D. HERSH from NYT Opinion https://ift.tt/38L2rhL
-
By BY NEW YORK TIMES AUDIO from NYT Podcasts https://ift.tt/MAm51p4
No comments:
Post a Comment